Get the Stockscreener App
0.23
6.68%
0.0144
After Hours:
.21
-0.02
-8.70%
cbdMD Inc stock is traded at $0.23, with a volume of 90,598.
It is up +6.68% in the last 24 hours and down -13.17% over the past month.
See More
Previous Close:
$0.2156
Open:
$0.21
24h Volume:
90,598
Relative Volume:
0.05
Market Cap:
$1.50M
Revenue:
$23.45M
Net Income/Loss:
$-19.98M
P/E Ratio:
-0.0182
EPS:
-12.63
Net Cash Flow:
$-2.65M
1W Performance:
-17.27%
1M Performance:
-13.17%
6M Performance:
-46.51%
1Y Performance:
-75.00%
1-Day Range:
$0.21
$0.23
1-Week Range:
$0.1811
$0.249
52-Week Range:
$0.1811
$1.2499
cbdMD Inc Stock (YCBD) Company Profile
Compare YCBD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
YCBD
cbdMD Inc
|
0.23 | 1.50M | 23.45M | -19.98M | -2.65M | -12.63 |
|
ZTS
Zoetis Inc
|
148.67 | 67.28B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.22 | 45.62B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.71 | 45.01B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.65 | 15.60B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
284.73 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
cbdMD Inc Stock (YCBD) Latest News
cbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock and Other Results from Annual Meeting - TradingView
cbdMD Eliminates $10.7M in Dividend Obligations: Major Financial Restructuring Approved - Stock Titan
Herbal Oasis Announces Distribution Agreement to Launch Statewide in Alabama and Select Florida Panhandle Markets - Quantisnow
SCHD ETF News, 4/7/2025 - The Globe and Mail
cbdMD Achieves Key Milestone in UK Novel Food Regulatory Approval - Newsfile
Major Breakthrough: cbdMD First US Brand Nearing UK CBD Market Authorization - Stock Titan
CBD Massage Oils: The Ultimate CBD Relaxation - cbdMD
cbdMD (NYSEAMERICAN:YCBD) Stock Price Down 3.1% – Here’s Why - Defense World
cbdMD, Inc. Announces Closing of Underwritten Public Offering of 8.0% Series A Cumulative Convertible Preferred Stock and Full Exercise of Underwriter’s Over-allotment Option for Total Gross Proceeds of $16.5 Million - Business Wire
cbdMD’s Pet Brand, Paw CBD, Sees Sales Increase 64% from March 2020 Quarter to June 2020 Quarter - Business Wire
cbdMD, Inc. to Host Earnings Call - ACCESS Newswire
cbdMD (NYSEAMERICAN:YCBD) Stock Price Up 1.5% – Time to Buy? - Defense World
cbdMD announces additional conversions of its convertible notes - MSN
cbdMD, Inc. (AMEX:YCBD) Q1 2025 Earnings Call Transcript - Insider Monkey
cbdMD Achieves Profitability, Highlights Growth in Earnings Call - TipRanks
cbdMD targets growth with new product launches and improved profitability in Q1 2025 - MSN
cbdMD Inc (YCBD) Q1 2025 Earnings Call Highlights: Achieving Profitability and Debt-Free Status By GuruFocus - Investing.com Canada
cbdMD, Inc. Reports Improved Earnings Amid Industry Challenges - TipRanks
cbdMD posts first-quarter profit despite lower sales - Green Market Report
cbdMD Generates $5.1 Million in Revenue, Positive Earnings - Yahoo Finance
cbdMD, Inc. to Host Conference Call to Discuss December 31, 2024 First Quarter of Fiscal Year 2025 Results - The Kingston Whig-Standard
cbdMD Earnings: Strategic Financial Review & Market Position Update Coming Feb 13 - StockTitan
cbdMD Inc [YCBD] is 54.03% higher this YTD. Is it still time to buy? - The DBT News
A Look at cbdMD Inc (YCBD) Shares in the Recent Past Indicates Growth - SETE News
cbdMD Inc (YCBD)’s highs and lows: A closer look at its stock price fluctuations - US Post News
YCBD’s Stock Market Adventure: 62.61% YTD Growth Amidst Volatility - The InvestChronicle
cbdMD Joins Forces with The Barstool Fund to Aid Small Businesses - cbdMD
Taking on analysts’ expectations and winning: cbdMD Inc (YCBD) - SETE News
CBD Hemp Oil Consumption Market Predicted at 17.97%CAGR to Cross 24.08 Billion USD by 2032 | Riot CBD, - EIN News
cbdMD Announces It Has Fully Satisfied Its Notes - The Kingston Whig-Standard
cbdMD Eliminates All Debt Through Early Note Conversion, Strengthens Financial Position - StockTitan
cbdMD Announces Additional Conversions of Its Convertible Notes - The Kingston Whig-Standard
cbdMD discloses NYSE listing compliance notice - MSN
cbdMD receives NYSE non-compliance notice - MSN
cbdMD Faces NYSE American Delisting Risk Over $2M Equity Requirement Shortfall - StockTitan
cbdMD (AMEX:YCBD) Stock Quotes, Forecast and News Summary - Benzinga
cbdMD Expands Board with CEO T. Ronan Kennedy - MSN
cbdMD Strengthens Leadership: CEO Kennedy Joins Board After Successful Business Turnaround - StockTitan
cbdMD Announces Company's CEO Joins the Board of Directors - Newsfile
cbdMD Launches Line of CBD Products with Wegmans Food Markets - Newsfile
cbdMD posts lower annual sales, mixed fourth quarter - Green Market Report
cbdMD Inc. (YCBD) reports earnings - Quartz
cbdMD Slashes Losses by $19.1M Despite Sales Dip; Launches New Product Lines - StockTitan
cbdMD, Inc. to Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results - The Kingston Whig-Standard
Dream Industrial REIT (DIR-UN-T) QuotePress Release - The Globe and Mail
cbdMD, Inc. Reschedules Earnings Release and Conference Call - Newsfile
S&P 500 Information Technology [Sector] (SRIT) QuotePress Release - The Globe and Mail
cbdMD, Inc. To Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results - The Kingston Whig-Standard
YCBD Stock Touches 52-Week Low at $0.41 Amid Market Challenges - Investing.com
cbdMD Inc Stock (YCBD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):